标题
Antiretroviral dynamics determines HIV evolution and predicts therapy outcome
作者
关键词
-
出版物
NATURE MEDICINE
Volume 18, Issue 9, Pages 1378-1385
出版商
Springer Nature
发表日期
2012-09-03
DOI
10.1038/nm.2892
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Evolutionary dynamics of HIV at multiple spatial and temporal scales
- (2012) Alison L. Hill et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- A quantitative basis for antiretroviral therapy for HIV-1 infection
- (2012) Benjamin L Jilek et al. NATURE MEDICINE
- Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262)
- (2011) Babafemi Taiwo et al. AIDS
- Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy
- (2011) Alex Sigal et al. NATURE
- Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine
- (2011) V. F. Boltz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dose-response curve slope is a missing dimension in the analysis of HIV-1 drug resistance
- (2011) M. E. S. Sampah et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Critical Subset Model Provides a Conceptual Basis for the High Antiviral Activity of Major HIV Drugs
- (2011) L. Shen et al. Science Translational Medicine
- Selection of Resistant Bacteria at Very Low Antibiotic Concentrations
- (2011) Erik Gullberg et al. PLoS Pathogens
- Full-length HIV-1 Gag determines protease inhibitor susceptibility within in-vitro assays
- (2010) Ravindra K Gupta et al. AIDS
- Average Adherence to Boosted Protease Inhibitor Therapy, rather than the Pattern of Missed Doses, as a Predictor of HIV RNA Replication
- (2010) Jean‐Jacques Parienti et al. CLINICAL INFECTIOUS DISEASES
- Association between Detection of HIV‐1 DNA Resistance Mutations by a Sensitive Assay at Initiation of Antiretroviral Therapy and Virologic Failure
- (2010) Gonzague Jourdain et al. CLINICAL INFECTIOUS DISEASES
- Protease inhibitor monotherapy
- (2010) Ignacio Pérez-Valero et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Efavirenz concentrations in CSF exceed IC50 for wild-type HIV
- (2010) B. M. Best et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Estimation of the Initial Viral Growth Rate and Basic Reproductive Number during Acute HIV-1 Infection
- (2010) R. M. Ribeiro et al. JOURNAL OF VIROLOGY
- Recombination Rate and Selection Strength in HIV Intra-patient Evolution
- (2010) Richard A. Neher et al. PLoS Computational Biology
- Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance
- (2009) Edward M Gardner et al. AIDS
- Antiretroviral medication adherence and the development of class-specific antiretroviral resistance
- (2009) Edward M Gardner et al. AIDS
- The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml
- (2009) Jose R Arribas et al. AIDS
- Viremia, Resuppression, and Time to Resistance in Human Immunodeficiency Virus (HIV) Subtype C during First‐Line Antiretroviral Therapy in South Africa
- (2009) Christopher J. Hoffmann et al. CLINICAL INFECTIOUS DISEASES
- Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment–Naive Patients Significantly Impact Treatment Outcomes
- (2009) Birgitte B. Simen et al. JOURNAL OF INFECTIOUS DISEASES
- Compartmentalization and Clonal Amplification of HIV-1 Variants in the Cerebrospinal Fluid during Primary Infection
- (2009) G. Schnell et al. JOURNAL OF VIROLOGY
- Gag Determinants of Fitness and Drug Susceptibility in Protease Inhibitor-Resistant Human Immunodeficiency Virus Type 1
- (2009) C. M. Parry et al. JOURNAL OF VIROLOGY
- Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis
- (2009) Ravindra K Gupta et al. LANCET INFECTIOUS DISEASES
- Gag Mutations Strongly Contribute to HIV-1 Resistance to Protease Inhibitors in Highly Drug-Experienced Patients besides Compensating for Fitness Loss
- (2009) Elisabeth Dam et al. PLoS Pathogens
- Differential impact of adherence on long-term treatment response among naive HIV-infected individuals
- (2008) Viviane D Lima et al. AIDS
- Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs
- (2008) Lin Shen et al. NATURE MEDICINE
- Not All Missed Doses Are the Same: Sustained NNRTI Treatment Interruptions Predict HIV Rebound at Low-to-Moderate Adherence Levels
- (2008) Jean-Jacques Parienti et al. PLoS One
- Drug interactions modulate the potential for evolution of resistance
- (2008) J.-B. Michel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle
- (2008) A. R. Sedaghat et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started